ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes - Wikidata - awgldk - TriplyDB

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

http://www.wikidata.org/entity/Q24603675

about

Management of gastric and duodenal neuroendocrine tumors Pancreatic insulinomas: Laparoscopic management Update on surgical treatment of pancreatic neuroendocrine neoplasms PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature Insights into bombesin receptors and ligands: Highlighting recent advances Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Evolving management of insulinoma: Experience at a tertiary care centre Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Therapy for metastatic pancreatic neuroendocrine tumors.Zollinger-Ellison syndrome: classical considerations and current controversies.Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example.Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing's syndrome: treatment response with chemotherapy.Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review.Multiple Endocrine Neoplasia: Genetics and Clinical Management.Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.ACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing Cushing's syndrome: a case report Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor.Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.Pharmacotherapy of Zollinger-Ellison syndrome.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET.Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience.Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.Comparison of 68Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome.Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.Mixed large cell neuroendocrine carcinoma with squamous cell carcinoma of the rectum: Report of a rare case and review of the literature.

P2860

Q26738541-6FABEF1B-75C2-4DB5-8E5F-99F4C087D5CE Q26777226-1F53F865-66E1-4499-977E-3493BACAB247 Q26864361-556041E2-AA8C-4F33-BF5B-E18F4F327CEE Q26992201-76F4C1FA-E68B-48AC-801B-0D334B1C0E65 Q28081153-58A9CABE-DF5A-4869-92DA-DE6418409E37 Q30249051-F09934A9-281F-484C-A80D-D55BC9D5C338 Q33568921-709891B5-A0D5-497E-8270-33DAF0B75840 Q33569093-95F13072-ACDB-48AB-82DF-C5CC6D8F137D Q33606047-106B2FC9-962E-4699-A423-7472E084DD69 Q34130243-C04E56AD-1C57-46D9-892B-CBE1F5CA42F9 Q34157385-EA852405-2255-4903-9B57-D56D50C02CAD Q34248487-7AF38C04-4866-4FAC-AB44-66821EF09A4F Q34357869-BDA7F653-A090-4D62-9391-946A54E8B257 Q34390574-5C9F5D3F-DF29-4B1B-ACED-E43AA3AF4F65 Q34446086-2CB62928-A4BC-43FA-811F-02C0A33219AD Q34520056-16EFD919-7B78-4C19-8024-19D01A7679F8 Q34650411-80E75A8A-FD2E-42E0-AFE4-6696A1923313 Q35230486-CFABD003-890C-4C5E-973A-7CF966F9A067 Q35857794-0EE0F44D-D3BD-47AE-A86A-C7F5C15FD6C4 Q36060458-B2431E1A-EA98-42C4-9D36-EB55D2E28163 Q36063577-68BF4C60-DFD7-4F94-8360-FC71D374F441 Q36065003-55A08F60-1597-4465-84F8-7035B44208CD Q36336998-F88262BC-B88B-4694-8FDD-CAE7657C8CA4 Q36351873-FF167814-3829-4D6F-9A3C-D5FC38EEDE67 Q36465024-B3B03DC5-5DA5-4198-9BC3-2E5AD467E3B8 Q36558826-13A82072-3873-4432-8300-9BAE8DAEFC16 Q36558853-BAACB242-17BA-48EF-B488-768D38BECA7F Q36632665-2F7E3EC3-93BC-4ADE-A7DC-D5A3F3D25429 Q36849357-9B5BD939-9D1C-4EAD-8059-8DE0777240B8 Q36871673-38F8012B-8A58-41F6-80E8-E2DD9DC760B2 Q36891907-B9673CAF-A369-49D9-92FB-9ABF550F4CAC Q36961922-25F0D085-AD78-4FA8-88EF-E74AD805960C Q37017018-831C58E1-0F30-4D9F-96FC-B2AD63CEF39F Q37056120-FD9D51E8-542C-4E43-B98C-BBB4B14AED7D Q37117596-DCE99D2C-E933-4C34-8544-C1EC362C72C9 Q37125550-4CE734B5-AB7A-4852-A0A2-F3F1FDEA0020 Q37204860-2B34F4B8-887F-4F3E-B70D-C7A372DD0A07 Q37212932-25107990-024B-4C24-8867-82BB6B57FA07 Q37378933-BF7F5F33-FC5B-4051-9740-1F38E4B044F6 Q37385540-CFA83E47-51F7-4F29-9101-5C55B9CBA551

P2860

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

http://www.wikidata.org/entity/Q24603675

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@ast

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@en

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@nl

type

label

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@ast

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@en

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@nl

prefLabel

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@ast

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@en

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@nl

P1433

Q24603675-7FF94BE5-FF5A-4976-9F4A-B5788F14F9BA

P1476

Q24603675-A6EF0C39-23D1-4D05-B2D2-1B21F0DCBC4C

P2093

Q24603675-298B1EC0-28BE-4631-AA5B-381AB6F26BEA

Q24603675-3535C559-3ADD-4068-9C6F-109C46FAFBDF

Q24603675-61648E50-102C-4FEB-A237-3FFC5C6A40AE

Q24603675-75A50C1B-D483-4D1B-A806-3271BFF2282A

Q24603675-A202B98E-DB1F-4C1C-91FE-A228FB638A4D

Q24603675-AEFE7853-ECA8-46EE-A561-F2FB36B0C3CE

Q24603675-FC7D72D0-FFE2-4B35-9B57-9C3572264BC5

P2860

Q24603675-057BC814-571A-458B-877D-AE0E234B8AD3

Q24603675-057CFB30-DCD7-4901-9772-CFA767676B3E

Q24603675-05B089AF-2605-4726-B48A-1CD8C74BB0CC

Q24603675-05B79EC9-CBF8-438C-953A-7383D186DBAB

Q24603675-0603130F-766D-4A52-85DB-BCA6DEAA24B7

Q24603675-07EF4DCD-4F6D-4A0A-964D-9C693E140B79

Q24603675-09D9EEA1-16B4-4FFD-936A-56CF57C11BF2

Q24603675-0D282931-9651-4120-B5C5-BFC50B206D43

Q24603675-1005CE59-6E76-41F1-BA40-B534F2DC769E

Q24603675-11576F20-3A88-4A0A-B79D-16B886BB6C9B

P304

Q24603675-72BB4083-8F8F-4ADE-858A-74F786C056DF

P31

Q24603675-C24BB5A2-4C10-42C1-93E0-A9929025E89A

P3181

Q24603675-63A79411-4CB1-4494-A6C2-01F117AF2C21

P356

Q24603675-A4437F2B-13B0-478C-B14D-B116A1DD1894

P407

Q24603675-755A4EAE-F37F-43A2-8AD4-1E280E0E8A33

P433

Q24603675-5B326372-02AA-4D4A-8542-C4583A3E3616

P478

Q24603675-71E9643A-71B0-47C9-9FD7-5FF75F1D11B3

P50

Q24603675-17433A9F-E1A7-4A6A-9E33-C790530DF66C

Q24603675-970CF112-187D-4C99-BC6A-206B9C526AD7

Q24603675-9A3CCA7E-B4D2-4215-A5C3-8B4CD0F22C9F

P577

Q24603675-207AB982-10D2-42C4-889B-10000B80873E

P5875

Q24603675-992E12B2-EED8-4184-A17A-8FF7D228DAF6

P698

Q24603675-3C16F4BA-0B09-4344-AF64-D8CE28C8EE0F

P921

Q24603675-488AB371-84DB-4D25-8225-98730EC66EEC

Q24603675-C7615E88-C41C-41F7-A71D-BA21627E61F4

Q24603675-C9AD1C84-F46D-4710-90F9-D9232DEC6D8F

P932

Q24603675-45265277-5A8C-4811-89B0-148D322D31B8

P3181

P356

P1433

Neuroendocrinology

P1476

ENETS Consensus Guidelines for ...... atic endocrine tumor syndromes

@en

P2093

Gregory Kaltsas

http://www.w3.org/2001/XMLSchema#string

Guillaume Cadiot

http://www.w3.org/2001/XMLSchema#string

Maria L Brandi

http://www.w3.org/2001/XMLSchema#string

Paul Komminoth

http://www.w3.org/2001/XMLSchema#string

Ramon Salazar

http://www.w3.org/2001/XMLSchema#string

Reza Kianmanesh

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

Multiple endocrine neoplasia type 1 (MEN1)

Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden.

Hypoglycaemia following gastric bypass surgery--diabetes remission in the extreme?

Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.

Endocrine neoplasms of the pancreas: pathologic and genetic features.

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

P304

98-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

356742

http://www.w3.org/2001/XMLSchema#string

P356

10.1159/000335591

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Yves Scoazec

Wouter W de Herder

P577

2012-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221763466

http://www.w3.org/2001/XMLSchema#string

P698

22261919

http://www.w3.org/2001/XMLSchema#string

P921

neuroendocrine tumor

pancreatic cancer

P932

3701449

http://www.w3.org/2001/XMLSchema#string